[1]
2018. Nivolumab in Renal Cell Carcinoma: Current Trends and Future Perspectives. Journal of Kidney Cancer. 5, 1 (Feb. 2018), 15–18. DOI:https://doi.org/10.15586/jkcvhl.2018.102.